One of the most comprehensive carrier screens available, providing accurate, actionable insights into carrier status for a broad range of hereditary conditions to help patients make more informed pregnancy planning choices. Learn more
about the benefits of our latest offering.
Comprehensively screens for common chromosome aneuploidies, sex chromosome aneuploidies, and microdeletion syndromes, with the flexibility to order select components of the test. Learn more
Detects 193 childhood conditions, many of which can’t be detected by carrier screening, standard prenatal tests, or state newborn screening alone. Also includes a pharmacogenomic (PGx) analysis of a child’s response to more than 40 medications that may be prescribed during childhood, including common antibiotics. Learn more
Offers a menu of panels to help you and your patients understand their individual risk for developing cancer or to inform treatment decisions. These tests are enabled through a set of digital tools and services to support easy identification, ordering, resulting, counseling, and access to testing. Learn more